Literature DB >> 11112504

The 2000 Olympic Games of protein structure prediction; fully automated programs are being evaluated vis-à-vis human teams in the protein structure prediction experiment CAFASP2.

D Fischer1, A Elofsson, L Rychlewski.   

Abstract

In this commentary, we describe two new protein structure prediction experiments being run in parallel with the CASP experiment, which together may be regarded as the 2000 Olympic Games of structure prediction. The first new experiment is CAFASP, the Critical Assessment of Fully Automated Structure Prediction. In CAFASP, the participants are fully automated programs or Internet servers, and here the automated results of the programs are evaluated, without any human intervention. The second new experiment, named LiveBench, follows the CAFASP ideology in that it is aimed towards the evaluation of automatic servers only, while it runs on a large set of prediction targets and in a continuous fashion. Researchers will be watching the 2000 protein structure prediction Olympic Games, to be held in December, in order to learn about the advances in the classical 'human-plus-machine' CASP category, the fully automated CAFASP category, and the comparison between the two.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112504     DOI: 10.1093/protein/13.10.667

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  3 in total

1.  Exploring the sequence-structure protein landscape in the glycosyltransferase family.

Authors:  Ziding Zhang; Sunil Kochhar; Martin Grigorov
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

2.  LiveBench-8: the large-scale, continuous assessment of automated protein structure prediction.

Authors:  Leszek Rychlewski; Daniel Fischer
Journal:  Protein Sci       Date:  2005-01       Impact factor: 6.725

Review 3.  The evaluation of protein structure prediction results.

Authors:  Domenico Cozzetto; Alejandro Giorgetti; Domenico Raimondo; Anna Tramontano
Journal:  Mol Biotechnol       Date:  2007-12-11       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.